As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio

scientific article published on December 2013

As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1037988919
P356DOI10.1007/S10753-013-9675-2
P698PubMed publication ID23794006
P5875ResearchGate publication ID241694226

P2093author name stringMukremin Uysal
Ahmet Ahsen
Memnune Sena Ulu
Seref Yuksel
Gursel Acarturk
Kasım Demir
Mujgan Erdogan
P2860cites workCountry as the primary risk factor for renal amyloidosis in familial Mediterranean fever.Q40451318
Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter studyQ40517425
Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever.Q40551397
MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis?Q40618094
Familial Mediterranean fever: effects of genotype and ethnicity on inflammatory attacks and amyloidosisQ40621952
Genotype-phenotype correlation in a large group of Turkish patients with familial mediterranean fever: evidence for mutation-independent amyloidosisQ40626660
Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosisQ40639120
Ratio of neutrophil to lymphocyte counts--rapid and simple parameter of systemic inflammation and stress in critically ill.Q42043513
The relationship between neutrophil-to-lymphocyte ratio and inflammation in end-stage renal disease patientsQ43746428
Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease.Q45343724
The leucocyte count: correlates and relationship to coronary risk factors: the CARDIA studyQ46785968
Familial Mediterranean fever at the millennium. Clinical spectrum, ancient mutations, and a survey of 100 American referrals to the National Institutes of Health.Q47611050
Familial Mediterranean fever.Q53649569
Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean FeverQ56288694
MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean feverQ58273510
Pyrin/marenostrin mutations in familial Mediterranean feverQ74453988
C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillationQ77337410
Acute phase response and evolution of familial Mediterranean feverQ77397098
The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failureQ79760043
Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarctionQ80841277
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancerQ81105891
Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndromeQ81934952
Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney diseaseQ85324071
Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitisQ85843857
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutationsQ24300638
Neutrophilia predicts death and heart failure after myocardial infarction: a community-based studyQ33772513
Phenotype-genotype correlation in 91 patients with familial Mediterranean fever reveals a high frequency of cutaneomucous featuresQ34086383
The spectrum of Familial Mediterranean Fever (FMF) mutationsQ34314032
MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implicationsQ34390765
Inflammation as a risk factor for atrial fibrillationQ34543274
Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV geneQ35550032
Acute phase response in familial Mediterranean feverQ35550951
Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian populationQ35750759
Familial mediterranean fever in Arabs.Q36431512
The M694V mutation in Armenian-Americans: a 10-year retrospective study of MEFV mutation testing for familial Mediterranean fever at UCLA.Q36605185
Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patientsQ38921330
Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF).Q38971609
Prevalence of juvenile chronic arthritis and familial Mediterranean fever in Turkey: a field study.Q39482483
Familial Mediterranean fever. A survey of 470 cases and review of the literatureQ40051008
Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarctionQ40180334
Results from a multicentre international registry of familial Mediterranean fever: impact of environment on the expression of a monogenic disease in childrenQ40255424
Down-regulation of adiponectin in patients with familial Mediterranean fever during attack-free period.Q40313887
Increased serum osteoprotegerin levels associated with decreased bone mineral density in familial Mediterranean feverQ40393028
The clinical and genetical features of 124 children with Familial Mediterranean fever: experience of a single tertiary centerQ40401212
The relationship between the MEFV genotype, clinical features, and cytokine-inflammatory activities in patients with familial mediterranean feverQ40426204
P433issue6
P921main subjectfamilial Mediterranean feverQ1144618
P304page(s)1357-1362
P577publication date2013-12-01
P1433published inInflammationQ2560341
P1476titleAs a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio
P478volume36